TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 NOK)
| Closing information | 2023/08 | 2022/08 | 2021/08 |
| Turnover |
29
|
17
|
0 |
| Financial expenses |
18
|
17
|
18 |
| Earnings before taxes |
-10
|
-18
|
-33 |
| EBITDA |
8
|
-2
|
-14 |
| Total assets |
1,440
|
1,350
|
1,469 |
| Current assets |
56
|
45
|
41 |
| Current liabilities |
888
|
820
|
869 |
| Equity capital |
552
|
530
|
600 |
| - share capital |
98
|
92
|
101 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Solvency |
38.3%
|
39.3%
|
40.8% |
| Turnover per employee |
29
|
17
|
0 |
| Profit as a percentage of turnover |
-34.5%
|
-105.9% | |
| Return on assets (ROA) |
0.6%
|
-0.1%
|
-1.0% |
| Current ratio |
6.3%
|
5.5%
|
4.7% |
| Return on equity (ROE) |
-1.8%
|
-3.4%
|
-5.5% |
| Change turnover |
12
|
17
|
0 |
| Change turnover % | 67% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/08 | 2022/08 | 2021/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.